PD Dr. med. Sergio B. Cogliatti
Leitende(r) Arzt/Ärztin
Pathologie · Dept. IV
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
Koster K, Messerich N, Volken T, Cogliatti S, Lehmann T, Graf L, Holbro A, Benz R, Demmer I, Jochum W, Rao T, Silzle T. Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study. Cancers (Basel) 2023; 15
24.09.2023Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
24.09.2023Cancers (Basel) 2023; 15
Koster Kira-Lee, Messerich Nora-Medea, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Graf Lukas, Holbro Andreas, Benz Rudolf, Demmer Izadora, Jochum Wolfram, Rao Tata Nageswara, Silzle Tobias
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Messerich N, Uda N, Volken T, Cogliatti S, Lehmann T, Holbro A, Benz R, Graf L, Gupta V, Jochum W, Demmer I, Rao T, Silzle T. CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study. Cancers (Basel) 2023; 15
25.02.2023CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
25.02.2023Cancers (Basel) 2023; 15
Messerich Nora-Medea, Uda Narasimha Rao, Volken Thomas, Cogliatti Sergio B., Lehmann Thomas, Holbro Andreas, Benz Rudolf, Graf Lukas, Gupta Vikas, Jochum Wolfram, Demmer Izadora, Rao Tata Nageswara, Silzle Tobias
Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
Brune M, Cogliatti S, Ossenkoppele G, Löwenberg B, Rudolf C, Li Q, Passweg J, Mazzuchelli L, Medinger M, Tzankov A, Fehr M, Grobholz R, Stussi G, Lundberg P, Vela V, Heim D, Manz M, Haralambieva E, Pabst T, Banz Y, Bargetzi M, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK). Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Ann Hematol 2021; 100:1169-1179.
02.03.2021Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort
02.03.2021Ann Hematol 2021; 100:1169-1179
Brune Magdalena M, Cogliatti Sergio B., Ossenkoppele Gert J, Löwenberg Bob, Rudolf Christina Biaggi, Li Qiyu, Passweg Jakob, Mazzuchelli Luca, Medinger Michael, Tzankov Alexandar, Fehr Martin, Grobholz Rainer, Stussi Georg, Lundberg Pontus, Vela Visar, Heim Dominik, Manz Markus G, Haralambieva Eugenia, Pabst Thomas, Banz Yara, Bargetzi Mario, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK)
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
Araf S, Fitzgibbon J, Okosun J, Johnson P, Davies A, Rimsza L, Scott D, Graham T, Barrington S, Forrer F, Kumar E, Cogliatti S, Wang J, Bewicke-Copley F, Korfi K, Fehr M. Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma. Haematologica 2020; 105:318-321.
09.04.2020Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
09.04.2020Haematologica 2020; 105:318-321
Araf Shamzah, Fitzgibbon Jude, Okosun Jessica, Johnson Peter, Davies Andrew, Rimsza Lisa M, Scott David W, Graham Trevor A, Barrington Sally F, Forrer Flavio, Kumar Emil, Cogliatti Sergio B., Wang Jun, Bewicke-Copley Findlay, Korfi Koorosh, Fehr Martin
Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
Menter T, Hayoz S, Hawle H, Sander B, Mazzucchelli L, Grobholz R, Karjalainen-Lindsberg M, Cathomas G, Banz Y, Cogliatti S, Beiske K, Sundstrom C, Hultdin M, Kimby E, Zucca E, Tzankov A, Dirnhofer S. Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy. Br J Haematol 2020; 189:707-717.
03.02.2020Prognostic implications of the microenvironment for follicular lymphoma under immunomodulation therapy
03.02.2020Br J Haematol 2020; 189:707-717
Menter Thomas, Hayoz Stefanie, Hawle Hanne, Sander Birgitta, Mazzucchelli Luca, Grobholz Rainer, Karjalainen-Lindsberg Marja-Liisa, Cathomas Gieri, Banz Yara, Cogliatti Sergio B., Beiske Klaus, Sundstrom Christer, Hultdin Magnus, Kimby Eva, Zucca Emanuele, Tzankov Alexandar, Dirnhofer Stefan
The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma
Hartmann S, Hansmann M, Engert A, Rosenwald A, Möller P, Klapper W, Stein H, Quintanilla-Martinez L, Fend F, Cogliatti S, Ott G, Feller A, Bernd H, Mottok A, Plütschow A, Eichenauer D. The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma. Am J Hematol 2019; 94:1208-1213.
21.08.2019The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma
21.08.2019Am J Hematol 2019; 94:1208-1213
Hartmann Sylvia, Hansmann Martin-Leo, Engert Andreas, Rosenwald Andreas, Möller Peter, Klapper Wolfram, Stein Harald, Quintanilla-Martinez Leticia, Fend Falko, Cogliatti Sergio B., Ott German, Feller Alfred C, Bernd Heinz-Wolfram, Mottok Anja, Plütschow Annette, Eichenauer Dennis A
A modular transcriptome map of mature B cell lymphomas
Loeffler-Wirth H, Pott C, Schwaenen C, Trautmann H, Wessendorf S, Stein H, Szczepanowski M, Trümper L, Hummel M, Klapper W, Siebert R, Loeffler M, Binder H, Rosenwald A, Ott G, Kreuz M, Hopp L, Arakelyan A, Haake A, Cogliatti S, Feller A, Hansmann M, Lenze D, Möller P, Müller-Hermelink H, Fortenbacher E, Willscher E, German Cancer Aid consortium Molecular Mechanisms for Malignant Lymphoma. A modular transcriptome map of mature B cell lymphomas. Genome Med 2019; 11:27.
30.04.2019A modular transcriptome map of mature B cell lymphomas
30.04.2019Genome Med 2019; 11:27
Loeffler-Wirth Henry, Pott Christiane, Schwaenen Carsten, Trautmann Heiko, Wessendorf Swen, Stein Harald, Szczepanowski Monika, Trümper Lorenz, Hummel Michael, Klapper Wolfram, Siebert Reiner, Loeffler Markus, Binder Hans, Rosenwald Andreas, Ott German, Kreuz Markus, Hopp Lydia, Arakelyan Arsen, Haake Andrea, Cogliatti Sergio B., Feller Alfred C, Hansmann Martin-Leo, Lenze Dido, Möller Peter, Müller-Hermelink Hans Konrad, Fortenbacher Erik, Willscher Edith, German Cancer Aid consortium Molecular Mechanisms for Malignant Lymphoma
Novel and mutation and distinct genetic profiles in MALT lymphomas of different sites
Moody S, Goodlad J, Bi Y, Ashton-Key M, Robson A, Cogliatti S, Wu F, Wlodarska I, Vassiliou G, Raderer M, Liu H, Chuang S, Thompson J, Du M. Novel and mutation and distinct genetic profiles in MALT lymphomas of different sites. Haematologica 2018; 103:1329-1336.
19.04.2018Novel and mutation and distinct genetic profiles in MALT lymphomas of different sites
19.04.2018Haematologica 2018; 103:1329-1336
Moody Sarah, Goodlad John, Bi Yingwen, Ashton-Key Margaret, Robson Alistair, Cogliatti Sergio B., Wu Fangtian, Wlodarska Iwona, Vassiliou George, Raderer Markus, Liu Hongxiang, Chuang Shih-Sung, Thompson Joe Sneath, Du Ming-Qing
Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
Paul U, Stein H, Hansmann M, Möller P, Szczepanowski M, Burkhardt B, Pfreundschuh M, Schmitz N, Loeffler M, Trümper L, Siebert R, Cogliatti S, Feller A, Rosenwald A, Richter J, Stuhlmann-Laiesz C, Kreuz M, Nagel I, Horn H, Staiger A, Aukema S, Hummel M, Ott G, Spang R, Klapper W. Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC. Leuk Lymphoma 2017:1-9.
25.08.2017Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC
25.08.2017Leuk Lymphoma 2017:1-9
Paul Ulrike, Stein Harald, Hansmann Martin-Leo, Möller Peter, Szczepanowski Monika, Burkhardt Birgit, Pfreundschuh Michael, Schmitz Norbert, Loeffler Markus, Trümper Lorenz, Siebert Reiner, Cogliatti Sergio B., Feller Alfred C, Rosenwald Andreas, Richter Julia, Stuhlmann-Laiesz Christiane, Kreuz Markus, Nagel Inga, Horn Heike, Staiger Annette M, Aukema Sietse M, Hummel Michael, Ott German, Spang Rainer, Klapper Wolfram
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma
Moody S, Bi Y, Raderer M, Ashton-Key M, Goodlad J, Liu H, Cogliatti S, Chuang S, Robson A, Zeng N, Xue X, Dunn-Walters D, Ochoa Ruiz E, Clipson A, Wang M, Escudero-Ibarz L, Du M. Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma. J Pathol 2017; 243:3-8.
07.08.2017Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma
07.08.2017J Pathol 2017; 243:3-8
Moody Sarah, Bi Yingwen, Raderer Markus, Ashton-Key Margaret, Goodlad John, Liu Hongxiang, Cogliatti Sergio B., Chuang Shih-Sung, Robson Alistair, Zeng Naiyan, Xue Xuemin, Dunn-Walters Deborah, Ochoa Ruiz Eguzkine, Clipson Alexandra, Wang Ming, Escudero-Ibarz Leire, Du Ming-Qing
Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome
Fischer A, Bastian S, Cogliatti S, Mey U, Saub J, Schanz U, Padberg S, Hohloch K. Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome. Hematol Oncol 2017
06.07.2017Ibrutinib-induced rapid response in chemotherapy-refractory Richter's syndrome
06.07.2017Hematol Oncol 2017
Fischer Angela, Bastian Sara, Cogliatti Sergio B., Mey Ulrich, Saub Jenny, Schanz Urs, Padberg Sgier, Hohloch Karin
Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
Staiger A, Hartmann S, Möller P, Cogliatti S, Lenz G, Trümper L, Löffler M, Schmitz N, Pfreundschuh M, Rosenwald A, Ott G, Hansmann M, Lenze D, Ziepert M, Horn H, Scott D, Barth T, Bernd H, Feller A, Klapper W, Szczepanowski M, Hummel M, Stein H, German High-Grade Lymphoma Study Group. Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group. J Clin Oncol 2017; 35:2515-2526.
19.05.2017Clinical Impact of the Cell-of-Origin Classification and the MYC/ BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group
19.05.2017J Clin Oncol 2017; 35:2515-2526
Staiger Annette M, Hartmann Sylvia, Möller Peter, Cogliatti Sergio B., Lenz Georg, Trümper Lorenz, Löffler Markus, Schmitz Norbert, Pfreundschuh Michael, Rosenwald Andreas, Ott German, Hansmann Martin-Leo, Lenze Dido, Ziepert Marita, Horn Heike, Scott David W, Barth Thomas F E, Bernd Heinz-Wolfram, Feller Alfred C, Klapper Wolfram, Szczepanowski Monika, Hummel Michael, Stein Harald, German High-Grade Lymphoma Study Group
[Sitting just hurts!]
Knechtle B, Jäckel K, Rosemann T, Rüst C, Cogliatti S. [Sitting just hurts!]. Praxis (Bern 1994) 2015; 104:511-5.
06.05.2015[Sitting just hurts!]
06.05.2015Praxis (Bern 1994) 2015; 104:511-5
Knechtle Beat, Jäckel Kristian, Rosemann Thomas, Rüst Christoph A, Cogliatti Sergio B.
DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma
Schmid C, Robinson M, Scheifinger N, Müller S, Cogliatti S, Tzankov A, Müller A. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma. J Exp Med 2015; 212:775-92.
06.04.2015DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma
06.04.2015J Exp Med 2015; 212:775-92
Schmid Corina A, Robinson Mark D, Scheifinger Nicole A, Müller Sebastian, Cogliatti Sergio B., Tzankov Alexandar, Müller Anne
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
Horn H, Hansmann M, Möller P, Cogliatti S, Pfreundschuh M, Trümper L, Loeffler M, Glass B, Schmitz N, Ott G, Rosenwald A, Hartmann S, Lenze D, Ziepert M, Wartenberg M, Staiger A, Barth T, Bernd H, Feller A, Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, DSHNHL16. Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma. Leukemia 2015; 29:1564-70.
17.02.2015Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
17.02.2015Leukemia 2015; 29:1564-70
Horn H, Hansmann M-L, Möller P, Cogliatti Sergio B., Pfreundschuh M, Trümper L, Loeffler M, Glass B, Schmitz N, Ott G, Rosenwald A, Hartmann S, Lenze D, Ziepert M, Wartenberg M, Staiger A M, Barth T F E, Bernd H-W, Feller A C, Klapper W, Stuhlmann-Laeisz C, Hummel M, Stein H, DSHNHL16
Nasolacrimal duct obstruction caused by lymphoproliferative infiltration in the course of chronic lymphocytic leukemia
Litschel R, Siano M, Tasman A, Cogliatti S. Nasolacrimal duct obstruction caused by lymphoproliferative infiltration in the course of chronic lymphocytic leukemia. Allergy Rhinol (Providence) 2015; 6:191-4.
01.01.2015Nasolacrimal duct obstruction caused by lymphoproliferative infiltration in the course of chronic lymphocytic leukemia
01.01.2015Allergy Rhinol (Providence) 2015; 6:191-4
Litschel Ralph, Siano Marco, Tasman Abel-Jan, Cogliatti Sergio B.
Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
Lee C, Ashton-Key M, Cogliatti S, Rondeau S, Schmitz S, Ghielmini M, Cragg M, Johnson P. Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98). Br J Haematol 2014; 168:145-8.
21.08.2014Expression of the inhibitory Fc gamma receptor IIB (FCGR2B, CD32B) on follicular lymphoma cells lowers the response rate to rituximab monotherapy (SAKK 35/98)
21.08.2014Br J Haematol 2014; 168:145-8
Lee Chern Siang, Ashton-Key Margaret, Cogliatti Sergio B., Rondeau Stephanie, Schmitz Shu-Fang Hsu, Ghielmini Michele, Cragg Mark S, Johnson Peter
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG)
Hartmann S, Engert A, Hansmann M, Stein H, Rosenwald A, Möller P, Ott G, Feller A, Hummel M, Cogliatti S, Bernd H, Koch K, Bob R, Mottok A, Plütschow A, Eichenauer D, Klapper W. Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG). Br J Haematol 2014; 167:238-42.
26.06.2014Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma--a matched pair analysis from the German Hodgkin Study Group (GHSG)
26.06.2014Br J Haematol 2014; 167:238-42
Hartmann Sylvia, Engert Andreas, Hansmann Martin-Leo, Stein Harald, Rosenwald Andreas, Möller Peter, Ott German, Feller Alfred C, Hummel Michael, Cogliatti Sergio B., Bernd Heinz-Wolfram, Koch Karoline, Bob Roshanak, Mottok Anja, Plütschow Annette, Eichenauer Dennis A, Klapper Wolfram
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma
Burkhard R, Bhagat G, Cogliatti S, Rossi D, Gaidano G, Pasqualucci L, Novak U. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. Hematol Oncol 2014
04.02.2014BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma
04.02.2014Hematol Oncol 2014
Burkhard Regula, Bhagat Govind, Cogliatti Sergio B., Rossi Davide, Gaidano Gianluca, Pasqualucci Laura, Novak Urban
Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
Aukema S, Stein H, Trautmann H, Wessendorf S, Trümper L, Loeffler M, Spang R, Kluin P, Klapper W, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project, Schwaenen C, Szczepanowski M, Rosenwald A, Kreuz M, Kohler C, Rosolowski M, Hasenclever D, Hummel M, Küppers R, Lenze D, Ott G, Pott C, Richter J, Cogliatti S. Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma. Haematologica 2013; 99:726-35.
31.10.2013Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
31.10.2013Haematologica 2013; 99:726-35
Aukema Sietse M, Stein Harald, Trautmann Heiko, Wessendorf Swen, Trümper Lorenz, Loeffler Markus, Spang Rainer, Kluin Philip M, Klapper Wolfram, Siebert Reiner, Molecular Mechanisms in Malignant Lymphomas Network Project, Schwaenen Carsten, Szczepanowski Monika, Rosenwald Andreas, Kreuz Markus, Kohler Christian W, Rosolowski Maciej, Hasenclever Dirk, Hummel Michael, Küppers Ralf, Lenze Dido, Ott German, Pott Christiane, Richter Julia, Cogliatti Sergio B.